DermatologyNews.net

Dermatology Xagena

Search results for "Tremfya"

ECLIPSE trial has demonstrated superiority of Guselkumab versus Secukinumab in delivering PASI 90 responses in the treatment of moderate to severe plaque psoriasis at week 48

ECLIPSE trial has demonstrated that Guselkumab ( Tremfya ) was superior to Secukinumab ( Cosentyx ) in treating adults with moderate to severe plaque psoriasis for the primary endpoint assessed at wee ...

Superiority of Ixekizumab, an IL-17A inhibitor, versus Guselkumab, an IL-23/p19 inhibitor, in delivering total skin clearance at week 12 in people with moderate to severe plaque psoriasis: IXORA-R trial

Ixekizumab ( Taltz ) met the primary and all major secondary endpoints up to week 12 in the phase 4 IXORA-R study, which evaluated the efficacy and safety of Ixekizumab versus Guselkumab ( Tremfya ) i ...

Keywords

MedTV

Antibiotici nel trattamento della Broncopneumopatia Cronica Ostruttiva riacutizzata

Polmoniti comunitarie - Percorso Diagnostico-Terapeutico

Terapia Antibiotica per le Infezioni Urinarie Non-Complicate Cistite

Sinusiti Mascellari Odontogene

Terapia Antibiotica Empirica

Linee Guida per il Trattamento delle Sinusiti Batteriche Acute negli Adulti e nei Bambini

Ruolo della Betaistina nel trattamento di pazienti con sintomi vertiginose

Cosa fare di fronte al paziente che riferisce vertigini?

Resistenza batterica agli antibiotici

Basi per il corretto impiego degli antibiotici in Medicina Generale